Anti-RAGE (Receptor Advanced Glycation End products) Antibody Improves Diabetic Retinopathy in Rats via Hypoglycemic and Anti-inflammatory Mechanism
- سال انتشار: 1401
- محل انتشار: مجله گزارش های بیوشیمی و زیست شناسی مولکولی، دوره: 11، شماره: 3
- کد COI اختصاصی: JR_RBMB-11-3_004
- زبان مقاله: انگلیسی
- تعداد مشاهده: 129
نویسندگان
Department of Ophthalmology, Faculty of Medicine Universitas Sriwijaya/ Dr Moh Hoesin General Hospital, Palembang, Indonesia
Specialized Residency Training, Faculty of Medicine Universitas Sriwijaya/Dr Moh Hoesin General Hospital, Palembang, Indonesia.
Department of Ophthalmology, Faculty of Medicine Universitas Sriwijaya/ Dr Moh Hoesin General Hospital, Palembang, Indonesia.
Department of Ophthalmology, Faculty of Medicine Universitas Sriwijaya/ Dr Moh Hoesin General Hospital, Palembang, Indonesia.
چکیده
Background: Receptor advanced glycation end products (RAGE) activation plays an essential role in diabetic retinopathy (DR) progression. This study was aimed to explore the role of anti-RAGE antibodies (RAGE antagonists) in inhibiting DR progression through their hypoglycemic and anti inflammatory mechanism in diabetic retinopathy induced rats. Methods: A total of ۳۰ male Wistar rats were randomly divided into five group. The group was consisted of normal control group, DR group without treatment, DR group with anti-RAGE ۱ g/kg BW, ۱۰ g/kg BW, and ۱۰۰ g/kg BW. To assess the diabetic retinopathy, fundus photographs were taken every week using a camera with ۱۶x magnification placed in front of the rat's eyes. Blood glucose was checked by the glucose oxidase-peroxidase method. Retinal TNF- levels and VEGF were examined using an enzyme-linked immunosorbent assay (ELISA) kit. Results: The finding of this study showed that anti-RAGE treatment at dose of ۱۰ and ۱۰۰ g/kg BW, HbA۱c levels were significantly higher (p< ۰.۰۵) compared to the normal control group but significantly lower (p< ۰.۰۵) than in the diabetes group. The mean blood vessel diameter in the DR+anti-RAGE ۱۰ and ۱۰۰ g/kg BW groups was significantly lower than in the diabetic retinopathy group (p< ۰.۰۵). The administration of anti-RAGE ۱۰ and ۱۰۰ g/kg BW showed the ability to significantly reduce VEGF levels compared to the DR group (p< ۰.۰۵). Conclusions:This study revealed at doses of ۱۰ and ۱۰۰ g/kg BW, anti-RAGE antibodies improved diabetic retinopathy in Wistar rats through hypoglycemic effects and anti-inflammatory mechanisms.کلیدواژه ها
Anti-RAGE (Receptor Advanced Glycation End products), Diabetic Retinopathy, Glycated Hemoglobin A, Hypoglycemic Agents, Peroxidases, Vascular Endothelial Growth Factor Aاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.